Literature DB >> 3323646

The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.

I Walter-Sack1.   

Abstract

Plasma concentrations of an active compound vary between individuals and within a subject, even if the same drug dosage is used. These differences are related to variations of drug absorption from the gastrointestinal tract, of presystemic drug metabolism in the intestine or the liver, and of drug elimination from the systemic circulation, for instance by hepatic metabolism or renal excretion. All of these processes can be modified by nutrition. However it is necessary to emphasize the significance of the pharmaceutical formulation for variations of both drug absorption and elimination. The role of nutrition should receive adequate attention during therapeutic use of drugs as well as in drug disposition studies. Recent guidelines for the assessment of the systemic availability of drugs therefore do recommend nutrition to be controlled.

Entities:  

Mesh:

Year:  1987        PMID: 3323646     DOI: 10.1007/BF01726326

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  120 in total

1.  Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors:  A Melander; K Danielson; B Scherstén; E Wåhlin
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

Review 2.  Nutrition and chemical biotransformations in man.

Authors:  A H Conney; E J Pantuck; R Kuntzman; A Kappas; K E Anderson; A P Alvares
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

3.  Effect of a high protein meal on the bioavailability of verapamil.

Authors:  B G Woodcock; N Kraemer; N Rietbrock
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

Review 4.  The influence of nutrition on the systemic availability of drugs. Part I: Drug absorption.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-10-01

Review 5.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

6.  Drug metabolism in white vegetarians.

Authors:  M J Brodie; A R Boobis; E L Toverud; W Ellis; S Murray; C T Dollery; S Webster; R Harrison
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

Review 7.  Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.

Authors:  M A Peppercorn
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

8.  Effects of dietary protein on theophylline pharmacokinetics and caffeine and aminopyrine breath tests.

Authors:  D Juan; E M Worwag; D A Schoeller; A N Kotake; R L Hughes; M C Frederiksen
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

9.  Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions.

Authors:  A J Byrne; J J McNeil; P M Harrison; W Louis; A M Tonkin; A J McLean
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

10.  A comparison of the activity of five microbial enzymes in cecal content from rats, mice, and hamsters, and response to dietary pectin.

Authors:  I R Rowland; A K Mallett; A Wise
Journal:  Toxicol Appl Pharmacol       Date:  1983-06-15       Impact factor: 4.219

View more
  3 in total

Review 1.  The effects of food on drug bioavailability.

Authors:  P A Winstanley; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 2.  A Review of Food-Drug Interactions on Oral Drug Absorption.

Authors:  Jianyuan Deng; Xiao Zhu; Zongmeng Chen; Chun Ho Fan; Him Shek Kwan; Chi Ho Wong; Ka Yi Shek; Zhong Zuo; Tai Ning Lam
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

Review 3.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.